Compounds 1 and 2 appear to be specific toward the HH pathway, as both are able to drastically inhibit Gli1 protein expression in murine NIH3T3 cells and in human melanoma cells without significant effect on a panel of 46 kinases. The gene discussed is GLI1; the disease is melanoma.